HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marguerite Neerman-Arbez Selected Research

Marguerite Neerman-Arbez Research Topics

Disease

28Afibrinogenemia (Fibrinogen Deficiency)
11/2022 - 03/2003
20Hemorrhage
01/2024 - 11/2005
10Thrombosis (Thrombus)
12/2023 - 06/2007
5Cardiovascular Diseases (Cardiovascular Disease)
04/2021 - 10/2010
3Neoplasms (Cancer)
07/2021 - 01/2021
3Hemophilia A (Haemophilia)
07/2021 - 05/2006
3Venous Thrombosis (Deep-Vein Thrombosis)
04/2021 - 11/2020
3Hepatocellular Carcinoma (Hepatoma)
09/2012 - 10/2010
2Rare Diseases (Rare Disease)
09/2022 - 06/2016
2Inflammation (Inflammations)
07/2021 - 08/2015
2COVID-19
07/2021 - 10/2020
2Thromboembolism
07/2021 - 09/2013
2Disease Progression
01/2021 - 06/2016
2Acute-Phase Reaction
09/2015 - 08/2015
2Iron Deficiencies
02/2011 - 12/2009
2Familial Multiple Coagulation Factor Deficiency I
02/2008 - 05/2006
1Menorrhagia
06/2023
1Venous Thromboembolism
07/2021
1von Willebrand Diseases (von Willebrand's Disease)
07/2021
1Wounds and Injuries (Trauma)
01/2021
1Infections
01/2021
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2021
1Congenital Hypodysfibrinogenemia
01/2021
1Hepatitis
10/2020
1Common Variable Immunodeficiency
01/2020
1Carcinoma (Carcinomatosis)
01/2020
1Vascular System Injuries
01/2020
1Congenital Dysfibrinogenemia
01/2018
1Intracranial Thrombosis (Cerebral Thrombosis)
01/2018
1Rupture
06/2016
1Bone Cysts (Bone Cyst)
06/2016
1Hemorrhagic Disorders (Hemorrhagic Diathesis)
03/2010
1Disease Susceptibility (Diathesis)
06/2009
1Fibrosis (Cirrhosis)
07/2006
1Chronic Hepatitis (Chronic Active Hepatitis)
07/2006

Drug/Important Bio-Agent (IBA)

46Fibrinogen (Factor I)FDA Link
01/2024 - 03/2003
10FibrinIBA
12/2023 - 06/2007
7Nonsense Codon (Nonsense Mutation)IBA
12/2020 - 05/2003
4AntigensIBA
01/2024 - 09/2013
3Proteins (Proteins, Gene)FDA Link
04/2021 - 06/2007
3MicroRNAs (MicroRNA)IBA
09/2015 - 10/2010
2ThrombinFDA Link
09/2022 - 10/2008
2Interleukin-6 (Interleukin 6)IBA
09/2015 - 08/2015
2Messenger RNA (mRNA)IBA
09/2015 - 03/2003
2Glycine (Aminoacetic Acid)FDA LinkGeneric
04/2014 - 10/2008
2LuciferasesIBA
09/2012 - 01/2011
2IronIBA
02/2011 - 12/2009
2Peptides (Polypeptides)IBA
02/2008 - 11/2005
2Factor V (Coagulation Factor V)IBA
02/2008 - 05/2006
1von Willebrand FactorIBA
06/2023
1Factor VIII (Coagulation Factor VIII)IBA
06/2023
1AnticoagulantsIBA
07/2021
1MorpholinosIBA
04/2021
1Complementary DNA (cDNA)IBA
01/2021
1Hemostatics (Antihemorrhagics)IBA
01/2021
1Protein Isoforms (Isoforms)IBA
11/2020
1EverolimusFDA Link
01/2020
1fibrinogen NieuwegeinIBA
01/2018
1CytokinesIBA
08/2015
1Blood Proteins (Serum Proteins)IBA
08/2015
1Biomarkers (Surrogate Marker)IBA
08/2015
13' Untranslated Regions (3' UTR)IBA
08/2015
1Initiator Codon (Start Codon)IBA
09/2012
1RNA Splice SitesIBA
02/2011
1fibrinogen AalphaIBA
03/2010
1FibrinolysinFDA Link
03/2010
1Protein Sorting Signals (Signal Peptide)IBA
03/2010
1fibrinopeptides gammaIBA
10/2008
15' Untranslated Regions (5' UTR)IBA
02/2008
1LectinsIBA
02/2008
1Amino AcidsFDA Link
02/2008
1AmylasesFDA Link
07/2006
1RNA (Ribonucleic Acid)IBA
12/2004

Therapy/Procedure

3Lasers (Laser)
04/2021 - 11/2020
2Therapeutics
09/2013 - 06/2009
1Operative Surgical Procedures
01/2015